Advertisement

Black Widow Spider Bite: “Can’tWe Just Get a Divorce?”

  • Annaliese G. SeidelEmail author
  • Colin G. Kaide
Chapter

Abstract

Black widow spiders are found across the United States and worldwide. Building webs in uninhabited dark places such as barns, garages, fences, and woodpiles, these spiders only bite when unexpectedly disturbed. Black widow spider bites cause local pain with minimal swelling, and may present with greater systemic severity, including autonomic dysfunction and abdominal rigidity. The prognosis is good, and mortality is rare. Treatment is generally supportive and focuses on pain control, but the clinical presentation warrants ruling out other concerning diagnoses.

Keywords

Black widow Spider Bite Envenomation Alpha-latrotoxin Latrodectus Latrodectism 

Notes

Disclosure Statement

Annaliese Seidel: Nothing to disclose

Colin Kaide: Callibra, Inc-Discharge 123 Medical Software Company. Medical Advisory Board Portola Pharmaceuticals. I have no relationship with a commercial company that has a direct financial interest in subject matter or materials discussed in article or with a company making a competing product.

References

  1. 1.
    Monte AA, Bucher-Bartelson B, Heard KJ. A US perspective of symptomatic Latrodectus spp. envenomation and treatment: a National Poison Data System review. Ann Pharmacother. 2011;45(12):1491–8.CrossRefGoogle Scholar
  2. 2.
    Glatstein M, Carbell G, Scolnik D, Rimon A, Hoyte C. Treatment of pediatric black widow spider envenomation: a national poison center’s experience. Am J Emerg Med. 2018;36(6):998–1002.CrossRefGoogle Scholar
  3. 3.
    Rahmani F, Banan Khojasteh SM, Ebrahimi Bakhtavar H, Shahsavari Nia K, Faridaalaee G. Poisonous spiders: bites, symptoms, and treatment; an educational review. Emerg (Tehran). 2014;2(2):54–8.Google Scholar
  4. 4.
    Camp NE. Black widow spider envenomation. J Emerg Nurs. 2014;40(2):193–4.CrossRefGoogle Scholar
  5. 5.
    Auerbach PS, Cushing TA, Harris NS. Auerbach’s wilderness medicine. Seventh edition. Philadelphia: Elsevier; 2017. 2 volumes (xxxi, 2631, 76 pages) p.Google Scholar
  6. 6.
    Offerman SR, Daubert GP, Clark RF. The treatment of black widow spider envenomation with antivenin latrodectus mactans: a case series. Perm J. 2011;15(3):76–81.CrossRefGoogle Scholar
  7. 7.
    Isbister GK, Page CB, Buckley NA, Fatovich DM, Pascu O, MacDonald SP, et al. Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom evaluation (RAVE-II) study. Ann Emerg Med. 2014;64(6):620–8. e2.CrossRefGoogle Scholar
  8. 8.
    Shackleford R, Veillon D, Maxwell N, LaChance L, Jusino T, Cotelingam J, et al. The black widow spider bite: differential diagnosis, clinical manifestations, and treatment options. J La State Med Soc. 2015;167(2):74–8.PubMedGoogle Scholar
  9. 9.
    Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med. 1992;21(7):782–7.CrossRefGoogle Scholar
  10. 10.
    Clark RF. The safety and efficacy of antivenin Latrodectus mactans. J Toxicol Clin Toxicol. 2001;39(2):125–7.CrossRefGoogle Scholar
  11. 11.
    Dart RC, Bogdan G, Heard K, Bucher Bartelson B, Garcia-Ubbelohde W, Bush S, et al. A randomized, double-blind, placebo-controlled trial of a highly purified equine F(ab)2 antibody black widow spider antivenom. Ann Emerg Med. 2013;61(4):458–67.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Emergency Medicine, Wexner Medical Center at The Ohio State UniversityColumbusUSA

Personalised recommendations